Pancreatic Neoplasms  >>  Teysuno (gimeracil/oteracil/tegafur)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
NCT01946646: Phase I Study of TS-1 With Concurrent Radiotherapy to Treat Pancreatic Cancer

Terminated
1
10
RoW
S-1-CCRT
National Taiwan University Hospital, TTY Biopharm
Metastatic Pancreatic Cancer
01/17
01/17

Download Options